Literature DB >> 1547837

The detection of African horse sickness virus antigens and antibodies in young Equidae.

C Hamblin1, E C Anderson, P S Mellor, S D Graham, P P Mertens, J N Burroughs.   

Abstract

Four ponies were each inoculated with a different serotype of African horse sickness virus (AHSV) which had been passaged through cell culture in order to achieve attenuation. Three of the ponies died suddenly after showing mild clinical signs, the fourth pony remained clinically normal and was killed at day 38. Infectious AHSV was isolated from blood samples collected at intervals from all four ponies. Positive antigen ELISA reactions were only observed with blood samples from two of the ponies on the two days preceding death. Specific AHSV antibodies were detected by ELISA in serum samples from the other two ponies although one eventually died. African horse sickness viral antigens were detected by ELISA in post-mortem tissue samples collected from all four ponies. No infectious virus could be detected in tissue samples taken post-mortem from the pony which survived African horse sickness (AHS) infection. In the event of a suspected outbreak of AHS it is recommended that sera and heparinized blood should be tested for specific antibodies and AHSV antigen respectively. When available, post-mortem tissues, including spleen, heart, lung and liver, should also be tested for AHSV antigen. Although the ELISA used for the detection of AHSV antigen is highly sensitive and specific, negative ELISA results should be confirmed by virus isolation attempts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547837      PMCID: PMC2272180          DOI: 10.1017/s0950268800049645

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

1.  A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus.

Authors:  C Hamblin; S D Graham; E C Anderson; J R Crowther
Journal:  Epidemiol Infect       Date:  1990-04       Impact factor: 2.451

2.  Isolations of African horse sickness virus from vector insects made during the 1988 epizootic in Spain.

Authors:  P S Mellor; J Boned; C Hamblin; S Graham
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

3.  A serogroup specific enzyme-linked immunosorbent assay for the detection and identification of African horse sickness viruses.

Authors:  C Hamblin; P P Mertens; P S Mellor; J N Burroughs; J R Crowther
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

  3 in total
  3 in total

1.  Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Horse Sickness.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Eyal Klement; Jan Arend Stegeman; Simon Gubbins; Sotiria-Eleni Antoniou; Alessandro Broglia; Yves Van der Stede; Gabriele Zancanaro; Inma Aznar
Journal:  EFSA J       Date:  2021-02-03

2.  A serosurvey of bluetongue and epizootic haemorrhagic disease in a convenience sample of sheep and cattle herds in Zimbabwe.

Authors:  Stuart J G Gordon; Charlotte Bolwell; Chris W Rogers; Godfrey Musuka; Patrick Kelly; Alan Guthrie; Philip S Mellor; Chris Hamblin
Journal:  Onderstepoort J Vet Res       Date:  2017-11-14       Impact factor: 1.792

3.  The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe.

Authors:  Stuart J G Gordon; Charlotte Bolwell; Chris W Rogers; Godfrey Musuka; Patrick Kelly; Alan Guthrie; Philip S Mellor; Christopher Hamblin
Journal:  Onderstepoort J Vet Res       Date:  2017-05-10       Impact factor: 1.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.